September 2013

 

In this Supplement

Expanding EVAR Safely

How a truly low-profile system with novel sealing technology is advancing EVAR.

Issue

Supplement

Download a PDF of this supplement

Expanding EVAR Safely

With worldwide experience and promising outcomes of the global clinical trial, it is clear the next-generation Ovation™ endograft will accommodate a wider range of AAA patients with difficult anatomy.

By Manish Mehta, MD, MPH

Aortic Neck Dilatation: Causes and Effects

A look at the mechanisms of aortic neck dilatation and how they can be overcome with new technology.

By Sean P. Lyden, MD

Rethinking the Concept of Aortic Neck Length

Will the concept of proximal aortic neck length become obsolete as aortic endograft designs incorporate new sealing technologies?

By Jennifer L. Ash, MD; Nabeel R. Rana, MD; Ravishankar Hasanadka, MD; and Syed M. Hussain, MD

Overcoming the Challenges of Access and Seal

The Arizona Heart experience with the Ovation Prime™ stent graft system.

By Venkatesh G. Ramaiah, MD, FACS; Ayman Jamal, MD; and Mohammed Jabr, MD

A Less-Invasive Protocol for EVAR

Can lower-profile endografts improve the safety and efficiency of EVAR?

By Zvonimir Krajcer, MD

The Genesis of the Ovation Prime™ Abdominal Stent Graft Platform

Employing requirements-driven design and physical principles to engineer a new generation of EVAR therapy.

By Michael V. Chobotov, PhD
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.